With the newly completed OT-101 and IL-2 Phase 1 trial, Oncotelic is poised to begin further combination trials to determine the added efficacy of OT-101, IL-2, and CKIs in solid tumors such as lung ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

The shares of Romanian clothing manufacturer Braiconf (BVB: BRCR), located in Brăila on the Danube, surged by 12% on March 24 ...

A Nintendo Direct about the Switch 2 is coming next week, but Nintendo might have a Switch 1 presentation on tap for this ...